ArticleBreast cancer research and treatment2024

Combined transcriptome and proteome analysis reveals MSN and ARFIP2 as biomarkers for trastuzumab resistance of breast cancer.

Xiao Shi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.